The price you pay for Lenvima may depend on factors such as your dosage, whether you have health insurance, and the pharmacy you use. Financial assistance may be available to help you with the ...

Lenvima is taking on Bayer's Nexavar in liver cancer in Japan – a drug that has been on the market for around a decade. According to Hendler the uptake in Japan has been remarkable, and more ...

Merck & Co. and Eisai have to deal with the reality that yet another phase 3 trial of their combination of Keytruda and Lenvima didn’t exactly go their way. The Keytruda-Lenvima regimen ...

Phase 3 trial showed Keytruda-Lenvima improves progression-free survival and response rates in HER2-negative gastroesophageal cancer. Final analysis found no improvement in overall survival ...

Lenvima/Welireg combination showed the highest ORR (46.9%) and CBR (59%) among treatment arms in advanced ccRCC patients. Median progression-free survival was longest in the Lenvima/Welireg arm at ...

LEAP-015 was designed to evaluate the potential of Keytruda+Lenvima with chemotherapy in the first-line treatment of locally advanced unresectable or metastatic human epidermal growth factor ...